HALO logo
halo search icon
Benitec Biopharma Inc
Benitec Biopharma Inc
BNTC · NAS

Benitec Biopharma Inc

US$10.99

Price Arrow0.27 (2.52%)
20/05/2026 04:00:00 PM
All-ConsensusBig CandleEngulfing BullishHALO AllHALO Consensus ValueRecent Earnings upgrade
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Benitec Biopharma Inc Overview

BNTC Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Strong

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About BNTC

icon

Telephone

1.510.780.0819

icon

Address

3940 Trust Way, Hayward, CA 94545

Description

Benitec Biopharma, Inc. is a development-stage biotechnology company, which engages in the advancement of novel genetic medicines. The firm's proprietary platforms include DNA-directed RNA interference, or ddRNAi, combines RNA interference, or RNAi, with gene therapy to create medicines that facilitates sustained silencing of disease-causing genes following a single administration. It is developing ddRNAi-based therapeutics for chronic and life-threatening human conditions including Oculopharyngeal Muscular Dystrophy and Chronic Hepatitis B. The company was founded in 1995 and is headquartered in Hayward, CA.

BNTC Price Chart

Key Stats

Market Cap

US$368.28M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 9.85 - 17.15

Trade Value (12mth)

US$446,933.00

1 week

-6.7%

1 month

-18.66%

YTD

-14.82%

1 year

-21.55%

All time high

5610.27

Key Fundamentals

EPS 3 yr Growth

-97.20%

EBITDA Margin

0.00%

Operating Cashflow

-$24m

Free Cash Flow Return

-32.50%

ROIC

-52.30%

Interest Coverage

0.00

Quick Ratio

54.70

Other Data

Shares Outstanding (Fully Diluted)

49m

HALO Sector

Healthcare

Next Company Report Date

30-Sep-26

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

BNTC Announcements

Latest Announcements

DateAnnouncements
14 May 26
14 May 26
14 May 26
13 February 26
13 February 26

BNTC Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-14.12-5.51-1.05locklocklock
EPS (Fully Diluted)
$locklocklocklock-14.12-5.51-1.05locklocklock
Growth
%locklocklocklock62.76181locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Benitec Biopharma Inc (BNTC:NAS)?
Halo FAQ
The current share price of Benitec Biopharma Inc (BNTC:NAS) is USD$10.99.
What is the 52-week high share price for Benitec Biopharma Inc (BNTC:NAS)?
Halo FAQ
The 52-week high share price for Benitec Biopharma Inc (BNTC:NAS) is USD$17.15.
What is the 52-week low share price for Benitec Biopharma Inc (BNTC:NAS)?
Halo FAQ
The 52-week low share price for Benitec Biopharma Inc (BNTC:NAS) is USD$9.85.
What is the dividend yield for Benitec Biopharma Inc (BNTC:NAS)?
Halo FAQ
Benitec Biopharma Inc (BNTC:NAS) does not pay a dividend.
What was Benitec Biopharma Inc (BNTC:NAS) last dividend payment?
Halo FAQ
The last dividend payment of Benitec Biopharma Inc (BNTC:NAS) is USD$0.00.
What is the franking level for Benitec Biopharma Inc (BNTC:NAS)?
Halo FAQ
Benitec Biopharma Inc (BNTC:NAS) has a franking level of 0.00%.
In which sector is Benitec Biopharma Inc (BNTC:NAS) classified?
Halo FAQ
Benitec Biopharma Inc (BNTC:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.